May 15
Impact of Hearing Aid Service Model and Technology on Patient Outcomes
Interview with Yu-Hsiang Wu, MD, PhD and Todd Ricketts, PhD, authors of Impact of Hearing Aid Service Model and Technology on Patient Outcomes:A Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Hearing Aid Service Models, Technology, and Patient Outc ... Show More
17m 39s
Apr 24
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma
Interview with Kevin J. Contrera, MD, MPH, author of Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neoadjuvant Therapy for Mucosal Head and Neck Squamous ... Show More
12m 19s
Mar 2025
Over-the-Counter Hearing Aid–Enabled Earbuds
Interview with Alexander Chern, MD, author of Over-the-Counter Hearing Aid–Enabled Earbuds—Merging Hearing Health and Technology. Hosted by Paul C. Bryson, MD, MBA. Related Content: Over-the-Counter Hearing Aid–Enabled Earbuds—Merging Hearing Health and Technology
13m 31s
Nov 2024
CAR T Cells and T-Cell Therapies for Cancer
CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott, M ... Show More
18m 22s
May 13
Ep. 222 Survivorship in Head and Neck Cancer with Dr. Michael Moore and Heather Starmer, PhD, CCC-SLP
What does it take to improve quality of life after head and neck cancer? In this episode of Backtable ENT, guests Dr. Heather Starmer, a speech and language pathologist at Stanford University, and Dr. Michael Moore, a head and neck cancer surgeon at Indiana University explore the ... Show More
46m 43s
Apr 2024
T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD. Related Content: T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
19m 57s
Dec 2024
Top Takeaways from 2024: Interventional Cardiology with Deepak L. Bhatt, MD, MPH, MBA, FACC
In this interview, Deepak L Bhatt, MD, MPH, MBA, FACC, and Alison L. Bailey, MD FACC, discuss the Top Interventional Takeaways from 2024. Dr. Bhatt discusses the CLEAR SYNERGY, DanGer Shock, EARLY TAVR trials and more. Jolly SS, d’Entremont MA, Lee SF, et al., for the CLEAR Inv ... Show More
16m 1s
Sep 2024
Diagnosis and Treatment of Community-Acquired Pneumonia (CAP)
Community-acquired pneumonia is associated with approximately 740 000 hospitalizations and 41 000 deaths in the US annually. JAMA Review authors Scott A. Flanders, MD, and Valerie M. Vaughn, MD, MSc, discuss diagnosis and treatment of community-acquired pneumonia with JAMA Deputy ... Show More
22m 55s
Oct 2023
Clinical Challenges in Surgical Oncology: Gastrointestinal Stromal Tumors (GISTs)
Join the Behind the Knife Surgical Oncology Team as we discuss the presentation, work-up, and management of gastrointestinal stromal tumors (GISTs)!
Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Scie ... Show More
33m 5s